The Prescription Drugs Division focuses on treatment areas such as cardiology, oncology, gynecology, hematology and ophthalmology. With innovative prescription drug products, Bayer strives to help patients achieve the desired results while meeting the ever-increasing needs of doctors and medical payment agencies. Bayer's Prescription Drugs Division is headquartered in Beijing, China, and has factories in Beijing and Guangzhou. In order to meet the growing demand for products in the Chinese market, Bayer invested 100 million euros to increase the production capacity of the Beijing plant on a large scale. The capacity expansion plan aims to ensure a stable supply of high-quality products to meet the needs of Chinese patients for Bayer prescription drug products for cardiovascular disease and diabetes. In addition, the imaging diagnostics business of Bayer's Prescription Drugs Division provides globally renowned diagnostic imaging solutions. In the field of imaging diagnostics, Bayer's products in China include contrast agents, injection devices and information processing solutions.
Consumer health products
Bayer Health Consumer Goods is well-known in the global health consumer goods market. The division operates in more than 100 countries and has multiple production and R & D bases.
The division's long history of innovation began in 1899 with Bayer launching the world-renowned consumer goods brand: Bayer Aspirin ™. Bayer acquired Roche's OTC business in 2005 and completed its acquisition of Merck's global health consumer products business in October 2014. In November 2014, Bayer completed the acquisition of all shares of China Dianhong Pharmaceutical Group.
In addition to over-the-counter drug plants in Shanghai, Qidong and Kunming, in January 2016, Bayer announced the official opening of its new Chinese and western medicine factory in Majinpu, Yunnan. The plant is located in Majinpu Park, Kunming National High-tech Industrial Development Zone, and is Bayer's second largest OTC plant in the Asia-Pacific region. The opening of the factory will greatly increase Bayer's over-the-counter drug production capacity, provide consumers with more high-quality self-care solutions, and meet the diverse health needs of Chinese consumers.
Today, the Consumer Health Division provides consumers with the world's most prestigious and trusted medicines and dietary supplements. The product portfolio has strong brands and covers multiple medical categories, including allergies, analgesics, cardiovascular risk prevention, cough and cold, dermatology, foot care, gastrointestinal, nutritional supplements and sun protection.
At present, the Health Consumer Products Division sells various influential branded products in the Chinese market, including Daxi®, Elektro®, Kangwang®, Caritasm®, Eloxon®, Piconox®, White Plus Black®, Kenneth®, Velocity®, etc.
The Crop Science Division, as a provider of world-renowned crop protection solutions, has been committed to sustainable agricultural development and has continuously introduced innovative products to the market. Bayer has an efficient and innovative product portfolio, complete technical services and strong collaborative relationships with partners. These advantages enable the Crop Science Division to actively respond to the Chinese government's call to commit to the development of modern agriculture and help farmers improve crop health. , Crop yields, bringing more revenue.
For more than 60 years, Bayer has been active in China's agricultural sector and has long been committed to promoting new technologies to Chinese farmers, including insecticides in the early 1980s to kill the newly launched vegetable and fruit fungicide Lunasen in 2014. In March 2015, Crop Science launched six innovative products in China, covering rice, corn, wheat, fruit and vegetable crops. By 2020, more than 20 new products are planned to be launched.
As a global company, Bayer's production base in Hangzhou not only meets domestic demand, but also supplies products to farmers in Asia, North America and Latin America.
The Crop Science Division has already launched cooperation projects with the Ministry of Agriculture and the Chinese Academy of Agricultural Sciences, and has cooperated with government agencies in capacity building. In February 2014, in support of the government's plan to develop rural areas, Bayer and CITIC Trust Co., Ltd. formally signed the "Agreement on Modern Agricultural Science and Technology Innovation and Development Cooperation on Land Transfer". The cooperation aims to use the rich experience and expertise of both parties to introduce CITIC Trust's financial services and crop science technology and innovation into China's agricultural sector.
In the field of animal health, Bayer offers a range of animal health products for farm animals and pets. As a successful supplier in the field of veterinary medicine, its China headquarters and GMP factory are located in Chengdu, Sichuan.